The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
PTEN reconstitution alters glioma responses to c-Met pathway inhibition.
The Hugo Moser Research Institute at Kennedy Krieger, Baltimore, Maryland, USA. firstname.lastname@example.org
Anti-cancer drugs 2011;22(9):905-12.
Mutations/deletions of the tumor-suppressor phosphatase and tensin homolog PTEN result in PI3K/Akt pathway hyperactivation and potentially alter oncogenic responses to targeted receptor tyrosine kinase inhibitors. We previously showed that hepatocyte growth factor (HGF):c-Met pathway inhibition decreases tumor growth and oncogenic signaling responses in PTEN-null/Met+ gliomas. Here, we use two tet-on PTENwt-inducible glioma cell lines and xenograft models to examine the influence of PTEN on oncogenic signaling responses to HGF:c-Met pathway inhibitors. Reconstitution of PTEN inhibited Akt by more than 80% and inhibited cell growth by approximately 70-75% in both cell lines in vitro. C-Met inhibition alone inhibited in-vitro cell growth by approximately 80-85% and the magnitude of growth inhibition was not altered by combining PTEN reconstitution with c-Met inhibition. Combining PTEN reconstitution with Met inhibition arrested a higher percentage of cells in G(1)/G(0) phase of the cell cycle when compared with either PTEN reconstitution or c-Met inhibition alone. Both PTEN reconstitution alone and inhibiting autocrine HGF:c-Met signaling alone, using anti-HGF mAb, robustly inhibited the growth of subcutaneous and intracranial glioma xenografts. Combining anti-HGF therapy with PTEN reconstitution did not significantly alter the magnitude of xenograft growth inhibition. Semiquantitative immunohistopathological analyses revealed that the inhibition of glioma xenograft angiogenesis and cell proliferation by anti-HGF mAb was greatest in conjunction with PTEN reconstitution. In contrast, xenograft cell apoptosis was greatest in response to anti-HGF therapy alone and PTEN reconstitution abrogated the apoptotic response to anti-HGF therapy. These results provide new insights into how PTEN modulates glioma responses to the inhibition of HGF:c-Met signaling and possibly other receptor tyrosine kinase pathways.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Bachchu Lal; C Rory Goodwin; Yingying Sang; Catherine A Foss; Kathrine Cornet; Sameena Muzamil; Martin G Pomper; Jin Kim; John LaterraMolecular cancer therapeutics 2009;8(7):1751-60.
Yunqing Li; Angela Li; Martin Glas; Bachchu Lal; Mingyao Ying; Yingying Sang; Shuli Xia; Daniel Trageser; Hugo Guerrero-Cázares; Charles G Eberhart; et al.Proceedings of the National Academy of Sciences of the United States of America 2011;108(24):9951-6.
Hui-Fang Li; Adam Keeton; Michele Vitolo; Clinton Maddox; Lynn Rasmussen; Judith Hobrath; E Lucille White; Ben Ho Park; Gary A Piazza; Jung-Sik Kim; et al.Journal of biomolecular screening 2011;16(4):383-93.
Appears in this Publication
Author of this Publication